104 related articles for article (PubMed ID: 29157864)
1. New Caspase-1 inhibitor by scaffold hopping into bio-inspired 3D-fragment space.
Brethon A; Chantalat L; Christin O; Clary L; Fournier JF; Gastreich M; Harris CS; Isabet T; Pascau J; Thoreau E; Roche D; Rodeschini V
Bioorg Med Chem Lett; 2017 Dec; 27(24):5373-5377. PubMed ID: 29157864
[TBL] [Abstract][Full Text] [Related]
2. Rational approach to identify newer caspase-1 inhibitors using pharmacophore based virtual screening, docking and molecular dynamic simulation studies.
Patel S; Modi P; Chhabria M
J Mol Graph Model; 2018 May; 81():106-115. PubMed ID: 29549805
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship study of a series of caspase inhibitors containing γ-amino acid moiety for treatment of cholestatic liver disease.
Mou J; Wu S; Luo Z; Guo F; He H; Wang J; Lin F; Guo F; Sun J; Shen L; Zeng M; Wang C; Xu D; Gu Z; Tian X; Zhang A; Xu H; Yang L; Zhang X; Li J; Chen S
Bioorg Med Chem Lett; 2018 Jun; 28(10):1874-1878. PubMed ID: 29650287
[TBL] [Abstract][Full Text] [Related]
4. Variation of the aryl substituent on the piperazine ring within the 4-(piperazin-1-yl)-2,6-di(pyrrolidin-1-yl)pyrimidine scaffold unveils potent, non-competitive inhibitors of the inflammatory caspases.
Kent CR; Bryja M; Gustafson HA; Kawarski MY; Lenti G; Pierce EN; Knopp RC; Ceja V; Pati B; Walters DE; Karver CE
Bioorg Med Chem Lett; 2016 Nov; 26(22):5476-5480. PubMed ID: 27777011
[TBL] [Abstract][Full Text] [Related]
5. Fused Bicyclic Caspase-1 Inhibitors Assembled by Copper-Free Strain-Promoted Alkyne-Azide Cycloaddition (SPAAC).
Qian L; Zhang CJ; Wu J; Yao SQ
Chemistry; 2017 Jan; 23(2):360-369. PubMed ID: 27882694
[TBL] [Abstract][Full Text] [Related]
6. The design and synthesis of sulfonamides as caspase-1 inhibitors.
Harter WG; Albrect H; Brady K; Caprathe B; Dunbar J; Gilmore J; Hays S; Kostlan CR; Lunney B; Walker N
Bioorg Med Chem Lett; 2004 Feb; 14(3):809-12. PubMed ID: 14741295
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking based virtual screening of natural compounds as potential BACE1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis.
Kumar A; Roy S; Tripathi S; Sharma A
J Biomol Struct Dyn; 2016; 34(2):239-49. PubMed ID: 25707809
[TBL] [Abstract][Full Text] [Related]
8. Identification of new SUMO activating enzyme 1 inhibitors using virtual screening and scaffold hopping.
Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY
Bioorg Med Chem Lett; 2016 Feb; 26(4):1218-23. PubMed ID: 26810265
[TBL] [Abstract][Full Text] [Related]
9. 1,2-benzisothiazol-3-one derivatives as a novel class of small-molecule caspase-3 inhibitors.
Wu L; Lu M; Yan Z; Tang X; Sun B; Liu W; Zhou H; Yang C
Bioorg Med Chem; 2014 Apr; 22(8):2416-26. PubMed ID: 24656804
[TBL] [Abstract][Full Text] [Related]
10. Structure-based discovery of a novel non-peptidic small molecular inhibitor of caspase-3.
Sakai J; Yoshimori A; Nose Y; Mizoroki A; Okita N; Takasawa R; Tanuma S
Bioorg Med Chem; 2008 May; 16(9):4854-9. PubMed ID: 18387304
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design, synthesis and evaluation of 2,4-diaminopyrimidine derivatives as novel caspase-1 inhibitors.
Patel S; Modi P; Ranjan V; Chhabria M
Bioorg Chem; 2018 Aug; 78():258-268. PubMed ID: 29614437
[TBL] [Abstract][Full Text] [Related]
12. 4-alkoxy-3-arylfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.
Xiao ZP; Ouyang H; Wang XD; Lv PC; Huang ZJ; Yu SR; Yi TF; Yang YL; Zhu HL
Bioorg Med Chem; 2011 Jul; 19(13):3884-91. PubMed ID: 21669535
[TBL] [Abstract][Full Text] [Related]
13. A highly potent and selective caspase 1 inhibitor that utilizes a key 3-cyanopropanoic acid moiety.
Boxer MB; Quinn AM; Shen M; Jadhav A; Leister W; Simeonov A; Auld DS; Thomas CJ
ChemMedChem; 2010 May; 5(5):730-8. PubMed ID: 20229566
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of analogues of butyrolactone I and molecular model of its interaction with CDK2.
Braña MF; García ML; López B; de Pascual-Teresa B; Ramos A; Pozuelo JM; Domínguez MT
Org Biomol Chem; 2004 Jul; 2(13):1864-71. PubMed ID: 15227538
[TBL] [Abstract][Full Text] [Related]
15. Exploring the ring potential of 2,4-diaminopyrimidine derivatives towards the identification of novel caspase-1 inhibitors in Alzheimer's disease therapy.
Kumi RO; Soremekun OS; Issahaku AR; Agoni C; Olotu FA; Soliman MES
J Mol Model; 2020 Mar; 26(4):68. PubMed ID: 32130533
[TBL] [Abstract][Full Text] [Related]
16. From natural product-inspired pyrrolidine scaffolds to the development of new human Golgi α-mannosidase II inhibitors.
Cheng TJ; Chan TH; Tsou EL; Chang SY; Yun WY; Yang PJ; Wu YT; Cheng WC
Chem Asian J; 2013 Nov; 8(11):2600-4. PubMed ID: 23943613
[No Abstract] [Full Text] [Related]
17. Identification of diverse natural products as falcipain-2 inhibitors through structure-based virtual screening.
Wang L; Zhang S; Zhu J; Zhu L; Liu X; Shan L; Huang J; Zhang W; Li H
Bioorg Med Chem Lett; 2014 Mar; 24(5):1261-4. PubMed ID: 24530004
[TBL] [Abstract][Full Text] [Related]
18. Design of highly potent noncovalent thrombin inhibitors that utilize a novel lipophilic binding pocket in the thrombin active site.
Tucker TJ; Lumma WC; Mulichak AM; Chen Z; Naylor-Olsen AM; Lewis SD; Lucas R; Freidinger RM; Kuo LC
J Med Chem; 1997 Mar; 40(6):830-2. PubMed ID: 9083470
[No Abstract] [Full Text] [Related]
19. Insight into Transannular Cyclization Reactions To Synthesize Azabicyclo[X.Y.Z]alkanone Amino Acid Derivatives from 8-, 9-, and 10-Membered Macrocyclic Dipeptide Lactams.
Atmuri ND; Lubell WD
J Org Chem; 2015 May; 80(10):4904-18. PubMed ID: 25831452
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of N-acyl-substituted 1,2-benzisothiazol-3-one derivatives as caspase-3 inhibitors.
Li Z; Pan Y; Zhong W; Zhu Y; Zhao Y; Li L; Liu W; Zhou H; Yang C
Bioorg Med Chem; 2014 Dec; 22(24):6735-45. PubMed ID: 25468037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
